Inventor · disambiguated record
Martin Lange
Also filed as: LANGE MARTIN · LANGE MARTIN R
15 granted patents·9 pending applications·72 citations·filing 2013–2025
91Inventor score
Top patents by PatentIndex Score
24 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0294US11773070B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Oct 3, 2023·2 cites·9 claims
- 0392US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0490US12258323B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Mar 25, 2025·1 cites·15 claims
- 0590US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0690US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0790US11427553B2DihydrooxadiazinonesBAYER AG·Filed 2018·Granted Aug 30, 2022·4 cites·11 claims
- 0890US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0988US11142522B2Compounds, compositions and methods for cancer treatmentBROAD INST INC·Filed 2018·Granted Oct 12, 2021·4 cites·16 claims
- 1085US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 1183US2024366620A1Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2024·Application pending·0 cites
- 1279US10966986B2Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2017·Granted Apr 6, 2021·1 cites·8 claims
- 1375US9884094B2Method of treating diabetes mellitusNOVO NORDISK AS·Filed 2013·Granted Feb 6, 2018·6 cites·5 claims
- 1474US12053476B2Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2021·Granted Aug 6, 2024·0 cites·6 claims
- 1574US2024182452A16-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancerBAYER AG·Filed 2023·Application pending·0 cites
- 1670US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1769US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1867US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1965US12427153B21,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 2064US2023405015A1Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcomaBAYER AG·Filed 2023·Application pending·0 cites
- 2160US2025170136A11,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2025·Application pending·0 cites
- 2258US2019200624A1Nutritional compositions and methods of using sameLANGE MARTIN R·Filed 2017·Application pending·0 cites
- 2357US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2456US10925880B2Combination of PI3K-inhibitorsBayer Pharma AG·Filed 2017·Granted Feb 23, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Martin Lange files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →